Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.

L. Berzenji (Edegem, Belgium), D. Michaux (Edegem, Belgium), S. Yogeswaran (Edegem, Belgium), A. Van Breussegem (Edegem, Belgium), P. Lauwers (Edegem, Belgium), J. Raskin (Edegem, Belgium), J. Hendriks (Edegem, Belgium), J. Van Meerbeeck (Edegem, Belgium), P. Van Schil (Edegem, Belgium)

Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Session: Thoracic surgery: developments in diagnostics and outcomes
Session type: E-poster session
Number: 1718
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Berzenji (Edegem, Belgium), D. Michaux (Edegem, Belgium), S. Yogeswaran (Edegem, Belgium), A. Van Breussegem (Edegem, Belgium), P. Lauwers (Edegem, Belgium), J. Raskin (Edegem, Belgium), J. Hendriks (Edegem, Belgium), J. Van Meerbeeck (Edegem, Belgium), P. Van Schil (Edegem, Belgium). Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.. 1718

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience
Source: International Congress 2017 – General thoracic surgery
Year: 2017

Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Malignant pleural mesothelioma:a 16-year, single centre experience
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014



Polychemotherapy experience in pleural mesothelioma with or without pemetrexed
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009


Second-line chemotherapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Malignant pleural mesothelioma: our multimodality approach
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002

A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Role of surgery and of radiotherapy in malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020


Malignant pleural mesothelioma: CT findings in 49 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002

Multimodal therapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002

Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004